Nps - neuropeptide S Gene

Species: Mus musculus

Gene Type: protein coding
Gene ID: 100043254

Summary

Acts upstream of or within positive regulation of action potential; positive regulation of synaptic transmission; and visual learning. Predicted to be located in extracellular region. Orthologous to human NPS (neuropeptide S). [provided by Alliance of Genome Resources, Apr 2022]

Nps Products (1)

mRNA Protein Name
NM_001163611.1 NP_001157083.1 neuropeptide S precursor

Gene Ontology

  • Biological Process
Biological Process GO Annotation Evidence References Source
acts upstream of or within positive regulation of action potential IDA
IDA: Inferred from direct assay
21437203 MGI
acts upstream of or within positive regulation of synaptic transmission, GABAergic IDA
IDA: Inferred from direct assay
21437203 MGI
acts upstream of or within positive regulation of synaptic transmission, glutamatergic IDA
IDA: Inferred from direct assay
21437203 MGI
acts upstream of synaptic transmission, glutamatergic IDA
IDA: Inferred from direct assay
21437203 MGI
acts upstream of or within visual learning IDA
IDA: Inferred from direct assay
19429110 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

neuropeptide S

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (4)
Cat. No. Product Name Effect
Purity Phase
HY-17633 Fonadelpar Agonist / Phase 3
HY-10007 NPS-2143 Antagonist 99.94% Phase 2
HY-10167A Tecalcet Hydrochloride Modulator 99.43% Phase 2
HY-106397 Delucemine / Phase 1

Pre-clinical Phase

Bioactive Molecules (39)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-152229 G0-C14 ≥98.0% Unkown
HY-113469 Cyclic GMP 99.77% Unkown
HY-10171 NPS-2143 hydrochloride Antagonist 99.98% Unkown
HY-113469A Cyclic GMP sodium 99.89% Unkown
HY-P10646 Muscle homing peptide M12 99.65% Unkown
HY-D1724 IR-806 98.84% Unkown
HY-108626 ML154 Antagonist 99.59% Unkown
HY-100509 NPS-1034 98.0% Unkown
HY-11095 NPS 2390 99.90% Unkown
HY-D0917 NIR-Red Dead Cell-1 Dye ≥96.0% Unkown
HY-P2491 Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled 99.43% Unkown
HY-113469B Cyclic GMP TBAOH / Unkown
HY-121870A Dimethocaine hydrochloride 99.36% Unkown
HY-178078 PTX-SS-COOH / Unkown
HY-W654000 Cyclic GMP-13C,15N2 98.81% Unkown
HY-103090 NPS ALX Compound 4a Antagonist ≥99.0% Unkown
HY-P1438 Neuropeptide S(Rat) Agonist 99.57% Unkown
HY-P4582 Suc-Phe-Ala-Ala-Phe-pNA Substrate 99.74% Unkown
HY-W767865 Cyclic GMP sodium-13C5 99.03% Unkown
HY-W075770 Nickel(II) oxide ≥99.0% Unkown
HY-10167 Tecalcet Modulator / Unkown
HY-103090A NPS ALX Compound 4a dihydrochloride Antagonist / Unkown
HY-158220C Hyaluronic acid methacryloyl (MW 50000) / Unkown
HY-169434 LTB Inhibitor / Unkown
HY-170310 AP-238 Agonist / Unkown
HY-178794 AGU661 Inhibitor / Unkown
HY-D2314 Cyanine 7-amine chloride hydrochloride / Unkown
HY-RS09502 NPS Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W423643 Benzedrone / Unkown
HY-106397A Delucemine hydrochloride / Unkown
HY-138232 Lys-psi(CH2NH)-Trp(Nps)-OMe Inhibitor / Unkown
HY-176913 TA / Unkown
HY-182543 NPS-467 Activator / Unkown
HY-184611 Chitosan stabilized selenium nanoparticles / Unkown
HY-184613 Poreless polydopamine nanoparticles / Unkown
HY-RS17574 Nps Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24034 Nps Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W010713 Meso-tetraphenylchlorin / Unkown
HY-W440913 DSPE-PEG5000-Cy5 / Unkown
Bioactive MoleculesInhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P991886 ANX-M1 (Human IgG1) Inhibitor 99.0% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Nps NCBI NCBI:594857